Xbrane Biopharma AB (publ)
SSE:XBRANE.ST
2.085 (SEK) • At close February 20, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -322.028 | -172.513 | -188.376 | -226.026 | -166.037 | -13.115 | -44.935 | -33.222 | -11.551 | -2.574 | -2.107 | -0.834 |
| Afschrijvingen & Amortisatie
| 21.433 | 16.576 | 12.998 | 6.566 | 7.326 | 4.323 | 3.992 | 8.539 | 1.441 | 0.055 | 0 | 0 |
| Uitgestelde Inkomstenbelasting
| -1.833 | -25.421 | -9.064 | 0 | 12.351 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 1.833 | 8.845 | 4.551 | 1.293 | 2.092 | 0.978 | 0.433 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -119.156 | -30.732 | -38.415 | -18.628 | -7.27 | 54.869 | 4.283 | -14.677 | -1.979 | -0.151 | -0.09 | 0 |
| Vorderingen
| -85.132 | 1.699 | -61.086 | -51.325 | -28.286 | -46.36 | -7.441 | -5.106 | -2.093 | -0.005 | 0 | 0 |
| Voorraden
| -56.596 | -50.26 | -22.671 | -32.697 | 0 | -2.28 | -0.568 | -2.336 | -0.161 | 0 | 0 | 0 |
| Crediteuren
| 22.572 | 17.829 | 22.671 | 32.697 | 42.968 | 103.509 | 12.292 | -4.672 | 0.513 | 0 | 0 | 0 |
| Overig Werkkapitaal
| 22.572 | 17.829 | 22.671 | 32.697 | -21.952 | 57.149 | 4.851 | -12.341 | -1.818 | -0.044 | 0 | 0 |
| Overige Niet-Contante Posten
| 11.239 | 9.327 | -1.304 | -1.612 | 2.949 | -0.348 | 3.803 | -0.067 | -0.299 | 0.002 | 0 | 0.834 |
| Kasstroom uit Operationele Activiteiten
| -406.679 | -193.918 | -219.61 | -238.407 | -148.589 | 46.707 | -36.849 | -39.426 | -12.387 | -2.668 | -2.197 | 0 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -16.769 | -60.125 | -77.35 | -3.855 | -1.187 | -1.598 | -3.347 | -12.087 | -1.146 | -0.187 | 0 | 0 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.019 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -9.978 | -48.509 | -49.672 | 0 | 0 | 0 | 0 | -0.635 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -16.769 | -60.125 | -77.35 | -3.855 | -1.187 | -1.598 | -3.347 | -12.722 | -1.127 | -0.187 | 0 | 0 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -193.549 | -8.337 | -7.273 | -0.012 | -0.14 | -0.131 | -0.257 | -9.778 | -10 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 119.056 | 170.551 | 380.87 | 346.447 | 252.457 | 3.25 | 20.004 | 90.577 | 0 | 0.18 | 10.709 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -0.001 | -13.35 | -24.232 | -23.711 | -36.276 | 44.611 | -3.276 | -9.778 | 10 | 0.18 | 0 | 0 |
| Kasstroom uit Financieringsactiviteiten
| 298.696 | 148.864 | 349.365 | 322.724 | 216.041 | 47.73 | 16.728 | 80.799 | 10 | 0.18 | 10.709 | 0 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -4.485 | 4.046 | 1.393 | -1.52 | -3.039 | 0.23 | 0.033 | 0 | -0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -128.592 | -101.186 | 52.041 | 78.942 | 63.225 | 93.069 | -23.435 | 28.651 | -3.514 | -2.676 | 8.512 | 0 |
| Kaspositie aan het Einde van de Periode
| 65.402 | 193.994 | 295.18 | 243.139 | 164.197 | 100.972 | 7.903 | 31.338 | 2.688 | 6.201 | 8.877 | 0 |